Author: Reader, Janette ; Wiesner, Lubbe ; Jiménez-Díaz, Maria Belén ; Silue, Kigbafori D. ; White, Karen L. ; Fidock, David A. ; Angulo-Barturen, Iñigo ; Marsh, Kennan C. ; Vanaerschot, Manu ; Solapure, Suresh M. ; Fish, Paul V. ; Wittlin, Sergio ; Abay, Efrem ; Gamo, Francisco Javier ; de Kock, Carmen ; Paquet, Tanya ; Blasco, Benjamin ; Chibale, Kelly ; van der Watt, Mariëtte E. ; Basarab, Gregory S. ; Street, Leslie J. ; Siegl, Peter ; Price, Ric N. ; Brunschwig, Christel ; Lawrence, Nina ; Duffy, James ; Coetzer, Theresa L. ; Noviyanti, Rintis ; Wirjanata, Grennady ; Smith, Dennis A. ; Taylor, Dale ; Njoroge, Mathew ; Denti, Paolo ; Herreros, Esperanza ; Birkholtz, Lyn-Marie ; Leroy, Didier ; Rochford, Rosemary ; Nchinda, Aloysius T. ; Witty, Michael J. ; Marfurt, Jutta ; Le Manach, Claire ; McPhail, Jacob A. ; Gonzàlez Cabrera, Diego ; Charman, Susan A. ; Waterson, David ; Burke, John E. ; Mancama, Dalu ; Donini, Cristina

01 Sep 2018·Antimicrobial agents and chemotherapyQ2 · MEDICINE

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

Q2 · MEDICINE

Article

Author: Cabrera, Diego Gonzàlez ; Reader, Janette ; Wiesner, Lubbe ; Jiménez-Díaz, Maria Belén ; Silue, Kigbafori D. ; White, Karen L. ; Angulo-Barturen, Iñigo ; Fidock, David A. ; Marsh, Kennan C. ; Vanaerschot, Manu ; Solapure, Suresh M. ; Fish, Paul V. ; Wittlin, Sergio ; Gamo, Francisco Javier ; Abay, Efrem ; de Kock, Carmen ; Paquet, Tanya ; Blasco, Benjamin ; Chibale, Kelly ; Basarab, Gregory S. ; van der Watt, Mariëtte E. ; Street, Leslie J. ; Siegl, Peter ; Price, Ric N. ; Brunschwig, Christel ; Duffy, James ; Lawrence, Nina ; Coetzer, Theresa L. ; Noviyanti, Rintis ; Wirjanata, Grennady ; Smith, Dennis A. ; Taylor, Dale ; Njoroge, Mathew ; Herreros, Esperanza ; Denti, Paolo ; Birkholtz, Lyn-Marie ; Leroy, Didier ; Rochford, Rosemary ; Nchinda, Aloysius T. ; Marfurt, Jutta ; Witty, Michael J. ; Le Manach, Claire ; McPhail, Jacob A. ; Waterson, David ; Charman, Susan A. ; Burke, John E. ; Mancama, Dalu ; Donini, Cristina

The 2-aminopyridine MMV048 was the first drug candidate inhibiting Plasmodium phosphatidylinositol 4-kinase (PI4K), a novel drug target for malaria, to enter clinical development. In an effort to identify the next generation of PI4K inhibitors, the series was optimized to improve properties such as solubility and antiplasmodial potency across the parasite life cycle, leading to the 2-aminopyrazine UCT943.

100 Deals associated with UCT-943

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Malaria	Discovery	South Africa	University of Cape Town	-
Malaria	Discovery	South Africa	MMV Medicines for Malaria Venture	-

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

UCT-943

Overview

Basic Info

Structure/Sequence

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation